Received Oct 2, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| FLU3 | INFLUENZA (SEASONAL) (FLULAVAL) | GLAXOSMITHKLINE BIOLOGICALS | 1 | 5EF45 | IM / LA |
Patient received seasonal flu vaccine as part of annual flu vaccination series. She developed severe reaction initially presenting as chest pain, shortness of breath and bilateral hand numbness. Vitals were taken by clinic LVN. Patient initially refused to go to the emergency department and stated that this reaction sometimes happens with previous vaccines but goes away without any intervention. She opted to be taken to urgent care, which was in the same building. Urgent care decided to call emergency services and the patient was taken to the emergency department. Vaccine information data: MFT: Glaxo Smith Kline (Flulaval) Lot3 5EF45 Exp: 6/9/26 Drug dose: 0.5 mL Route: IM, L-deltoid
Ritlectinib 50 mg capsule daily, ondansetron 4 mg every 8 hours as needed, meclizine 12.5 mg three times daily as needed, calcium carbonate, cholecalciferol 1000 units daily
Latex, chlorhexidine, famciclovir, iodine
Vitals were taken when incident occurred 10/1/25. Patient was sent to Emergency Department (withheld)(Medical Center)